Cancer & Immunology Virtual Summit
SelectScience® Virtual Summit on Cancer and Immunology Research 2020 -
May 11-13, 2020
Opening at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT)
The full exciting schedule has been announced for the inaugural SelectScience® Virtual Summit on Cancer and Immunology Research.
Scientists and scientific manufacturers will come together next week to explore vital topics spanning research areas from COVID-19 and CAR T-cell therapy to CRISPR technology, liquid biopsies, and the microbiome. Taking place online from Monday, May 11, to Wednesday, May 13, the Summit will feature talks by top scientists and technology innovators, video interviews, virtual resource hubs, live Q&As and much more — all completely free of charge. Drop in and out of the Summit as you please to catch up on the latest research, techniques and technologies in your field and play your part in improving science communication by leaving a lab product review for a chance to win a $400 Amazon Gift Card.
"Science does not recognize borders, and this Virtual Summit represents a timely mechanism to collectively partner and envision next-generation technologies at a critical time in history. I commend SelectScience for their leadership; this Virtual Summit provides a necessary moment to pause from the global chaos and envision the science necessary to help the world." - Prof. Tim Long, Virginia Polytechnic Institute and State University & Virtual Analytical Summit 2020 keynote speaker
Monday, May 11
|
Opening address: Welcome to the SelectScience® Virtual Summit on Cancer and Immunology Research |
|
IDEM development for ovarian cancer treatment |
|
Personalized cancer vaccines based on self-assembling nanoparticles (SNAP) for inducing anticancer T cell immunity |
|
Live-Cell Analysis in 2020: Advancing Technology to meet Researchers' Needs |
|
Bioanalytical Strategies to Support Novel CAR-T Therapies |
|
Integrating molecular analysis and radiomic features to predict immunotherapy response in NSCLC patients |
|
Use of novel nanoplate-based digital PCR for liquid biopsies in the areas of cancer research |
|
Microbiome analyses of blood and tissues suggest cancer diagnostic approach |
|
High-content analysis and phenotypic characterization of 2D and 3D cellular models using confocal microscopy solutions |
|
Low light in vivo imaging of mice for cancer model research |
|
Exploring the tissue and tumor microenvironment with mass cytometry and Imaging Mass Cytometry |
Tuesday, May 12
|
Loss of ISG15 and ISGylation Reduces Pancreatic Cancer Stem Cell Mitophagy, Stemness and Metabolic Plasticity |
|
Assembling antibodies from modules using protein ligation: a new versatile engineering toolbox |
|
Dual Function pH Responsive Bispecific Antibodies for Tumor Targeting and Antigen Depletion in Plasma |
|
Label free imaging case study: Voltage-dependent activation of Rac1 by Nav1.5 channels promotes cell migration |
|
Scientists' Choice Awards™ Live Presentation |
|
Pancreatic cancer patient-derived organoids as a tool for personalized medicine |
|
Cell Production Incubator: Scale-up Culture Based Therapeutics |
|
ELISA automation: Increase throughput, accuracy and reproducibility with automated pipetting technology |
|
Modern CAR T cell-based assays for targeting solid tumors using image cytometry |
|
Functional in vitro assays to evaluate 2D and 3D cancer immunotherapy research models |
Wednesday, May 13
|
Considerations when generating diagnostic samples for ccfDNA analysis |
|
Expand your applications with novel blood collection tubes that maintain extracellular vesicles and cell-free RNA |
|
Quantifying the immuno-oncology microenvironment for a more personalised pathology |
|
Exploring nutrient-based intervention for colorectal cancer by mass spectrometry |
|
Sony ID7000™ Spectral Cell Analyzer |
|
Bringing Functional Diagnostics into the Clinic for Cancer Patients |
|
Targeted epigenome sequencing of cfDNA: Improve sensitivity for early cancer detection and ultra-sensitive residual leukemia detection |
|
High-plex imaging case study: Using NanoString Digital Spatial Profiling (DSP) to understand skin immune profile in Cutaneous Leishmaniasis |
|
Advances in Extracting and Stabilizing RNA: An Important Tool for Molecular Oncology |
|
Fluidic mechanoporation for highly effective gene delivery into hard-to-transfect primary cells |
Keynote Speakers
|
Prof. Steve Conlan University of Swansea IDEM development for ovarian cancer treatment |
|
Dr. Bruno Sainz Autónoma University of Madrid Loss of ISG15 and ISGylation reduces pancreatic cancer stem cell mitophagy, stemness and metabolic plasticity |
|
Dr. Amanda Hummon Ohio State University Exploring nutrient-based intervention for colorectal cancer by mass spectrometry |
Speakers
Integrating molecular analysis and radiomic features to predict immunotherapy response in NSCLC patients
Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Label free imaging case study: Voltage-dependent activation of Rac1 by Nav1.5 channels promotes cell migration
Pancreatic cancer patient-derived organoids as a tool for personalized medicine
Modern CAR T cell-based assays for targeting solid tumors using image cytometry
Functional in vitro assays to evaluate 2D and 3D cancer immunotherapy research models
Bringing Functional Diagnostics into the Clinic for Cancer Patients
High-plex imaging case study: Using NanoString Digital Spatial Profiling (DSP) to understand skin immune profile in Cutaneous Leishmaniasis
Fluidic mechanoporation for highly effective gene delivery into hard-to-transfect primary cells
|
Learn how IncuCyte® live-cell analysis can be used to fool-proof your oncology and immunology discoveries |
Hear how to scale up culture-based therapeutics with this cell production incubator |
|
|
Find out how spectral technology can address flow cytometry challenges that impact biomedical discovery |
Discover pH-responsive, bispecific antibodies for tumor targeting and antigen depletion in plasma |
|
|
Find out how to perform affordable ELISA automation with the ASSIST PLUS pipetting robot |
Learn more about low-light in vivo imaging of mice for cancer model research |
|
|
Revealed: A new innovation for site-directed conjugation of antibodies |
Improve sensitivity for early cancer detection with targeted epigenome cfDNA sequencing |
|
|
Discover novel bioanalytical strategies to support the development of CAR-T therapies |
Explore the development of personalized cancer vaccines based on self-assembling nanoparticles |
|
|
Find out how to quantify the immuno-oncology microenvironment for a more personalized pathology |
Explore the advances in extracting and stabilizing RNA for molecular oncology research |
|
|
Achieve high-content analysis and phenotypic characterization with the ImageXpress® Micro Confocal System |
Learn more about using image cytometry and CAR T cell-based assays for targeting solid tumors |
|
|
Discover the novel blood collection tubes that maintain extracellular vesicles and cell-free RNA |
Explore the use of novel nanoplate-based digital PCR for liquid biopsies in cancer research |
|
|
Learn about the considerations for generating diagnostic samples for ccfDNA analysis |
Find out how to explore the tissue and tumor microenvironment with imaging mass cytometry |
